Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00121212 · ClinicalTrials.gov registry record · NA
Positron Emission Tomography in Prostate Cancer
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
NCT00121212 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 179 participants.
The verdict
NCT00121212, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as positron emission tomography using carbon-11 acetate, may help find metastases from prostate cancer and may help predict whether prostate cancer will come back after treatment. PURPOSE: This clinical trial is studying how well positron emission tomography using carbon-11 acetate works in finding metastases and predicting recurrence in patients with prostate cancer who are at risk for recurrence after treatment.
Interventions
- PROCEDURE carbon-11 acetate PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2003-07 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00121212
The ClinicalTrials.gov registry entry for NCT00121212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which carbon-11 acetate PET scan is the first listed.
NCT00121212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00121212 about?
NCT00121212 is a clinical study titled "Positron Emission Tomography in Prostate Cancer". RATIONALE: Diagnostic procedures, such as positron emission tomography using carbon-11 acetate, may help find metastases from prostate cancer and may help predict whether prostate cancer will come back after treatment. PURPOSE: This clinical trial is studying how well positron emission tomography u...
What is the current status of trial NCT00121212?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2003-07. Estimated completion is 2015-10.
What interventions are being tested in trial NCT00121212?
The interventions under investigation include: carbon-11 acetate PET scan (PROCEDURE).
Who is sponsoring clinical trial NCT00121212?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.